Brief communication (Original). Correlation of glycated albumin with self blood glucose monitoring in diabetic patients on hemodialysis taking erythropoietin

1. Chujo K, Shima K, Tada H,Oohashi T, Minakuchi J, Kawashima S. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest. 2006; 53:223-8.10.2152/jmi.53.223Open DOISearch in Google Scholar

2. Inaba M, Okuno S, Kumeda Y, Yamada S, Inamishi Y, Tabata. T, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephro. 2007; 18:895-903.10.1681/ASN.2006070772Open DOISearch in Google Scholar

3. Peacock TP, Shihabi ZK, Bleyer, AJ Dolbare EL, Byers JR, Krovich MA, et al. Comparison of glycated albumin and hemoglobin A1c levels in diabetic patients on hemodialysis. Kidney Int. 2008; 73:1062-8.10.1038/ki.2008.25Search in Google Scholar

4. Freedman BI, Shenoy RN, Planer JA,Clay KD, Shihabi ZK, Burkart JM, et al. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int. 2010; 30:72-9.10.3747/pdi.2008.00243Search in Google Scholar

5. Viswanathan V, Kumpatla S, Tilak P, Muthukumaran P. Levels of glycated albumin at different stages of diabetic nephropathy in India. Int J Diabetes Metab. 2009; 17:77-80.10.1159/000497676Search in Google Scholar

6. Uzu T, Hatta T, Deji N, Izumiya T, Ueda H, Miyazawa I, et al. Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A1c. Ther Apheresis and Dialysis. 2009; 13:89-9410.1111/j.1744-9987.2009.00661.xSearch in Google Scholar

7. Mehrotra R, Kalantar-Zadeh K, Adler S. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? Clin J Am Soc Nephrol. 2011; 6:1520-2.10.2215/CJN.04210511Open DOISearch in Google Scholar

8. Nagayama H, Inaba M, Okabe R, Emoto M, Ishimura E, Okazaki S, Nishizawa Y, et al. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed Pharmacother. 2009; 63:236-40.10.1016/j.biopha.2008.04.002Search in Google Scholar

9. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-86.10.1056/NEJM199309303291401Search in Google Scholar

10. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352(9131):837-53.10.1016/S0140-6736(98)07019-6Search in Google Scholar

11. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2011, 47:453-63Search in Google Scholar

12. Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med. 1998; 37: 826-30.10.2169/internalmedicine.37.8269840702Open DOISearch in Google Scholar

13. Johnson RN, Baker JR. Error detection and measurement in glucose monitors. Clin Chim Acta. 2001; 307:1-67Search in Google Scholar

14. Riveline JP, Teynie J, Belmouaz S, Franc S, Dardari D, Bauwens M, et al. Glycaemic control of type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant. 2009, 24:2866-7110.1093/ndt/gfp18119389864Search in Google Scholar

15. Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology. 2012; 17:82-188.10.1111/j.1440-1797.2011.01517.x21883672Open DOISearch in Google Scholar

16. Tahara Y, Shima K. The response of GHb to step-wise plasma glucose change over time in diabetic patients. Diabetes Care. 1993; 16:1313-410.2337/diacare.16.9.13138404444Open DOISearch in Google Scholar

17. Yoshiuchi K, Matsuhisa M, Katakami N Nakatani Y, Sakamoto K, Matsuoka T, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J. 2008; 55:503-7.10.1507/endocrj.K07E-08918445997Open DOISearch in Google Scholar

18. Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J. 2010; 57:135-40.10.1507/endocrj.K09E-23419926921Open DOISearch in Google Scholar

19. Kisugi R, Kouzuma T, Yamamoto T, Akizuki S, Miyamoto H, Someya Y, et al. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin Chim Acta. 2007; 382: 59-64.10.1016/j.cca.2007.04.00117482589Search in Google Scholar